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Supplementary Table 1. Total populations and number of general practices included in the analysis, 2000-2016 
Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 
Age (years) Male Female Male Female Male Female Male Female Male Female Male Female Male Female Male Female Male Female 
35-44 147,146 143,069 192,375 186,864 245,165 237,195 274,374 265,655 293,239 283,990 322,740 312,407 331,807 321,398 338,033 327,871 352,097 343,055 
45-54 134,635 130,890 171,224 165,985 211,532 204,963 234,593 226,903 250,374 241,344 278,685 267,755 292,216 280,980 305,206 294,213 329,044 318,725 
55-64 104,872 103,631 139,539 138,391 183,785 182,029 209,814 207,039 226,874 224,316 252,700 250,203 263,821 261,290 272,227 269,999 289,329 288,320 
65-74 77,086 86,570 100,418 111,707 126,949 140,614 142,300 156,378 152,690 166,849 167,811 182,368 172,565 186,805 180,003 193,860 195,325 210,578 
75-84 44,026 66,121 57,925 85,603 74,035 108,279 83,083 120,123 89,301 128,132 98,133 137,854 101,442 140,197 105,881 143,935 113,035 151,339 
85+ 11,255 27,806 14,727 36,432 18,074 44,210 19,349 47,320 20,789 50,573 24,845 58,366 27,253 61,997 29,118 65,187 31,618 69,618 
Subtotal 519,020 558,087 676,208 724,982 859,540 917,290 963,513 1,023,418 1,033,267 1,095,204 1,144,914 1,208,953 1,189,104 1,252,667 1,230,468 1,295,065 1,310,448 1,381,635 
Total 1,077,107 1,401,190 1,776,830 1,986,931 2,128,471 2,353,867 2,441,771 2,525,533 2,692,083 
Practices 238 317 426 480 513 564 579 600 633 
Year 2009 2010 2011 2012 2013 2014 2015 2016   
Age (years) Male Female Male Female Male Female Male Female Male Female Male Female Male Female Male Female   
35-44 349,208 339,756 336,547 328,751 328,052 322,459 325,755 320,660 297,433 293,360 270,652 267,102 222,383 219,666 194,688 191,369   
45-54 338,554 328,792 341,173 332,701 344,598 337,961 353,446 346,843 333,165 327,949 307,773 304,307 254,925 252,629 221,876 219,830   
55-64 288,684 289,109 285,948 287,584 281,904 285,054 280,871 284,198 263,123 266,024 244,891 246,389 206,782 207,931 182,527 183,209   
65-74 201,451 217,050 202,249 217,433 209,428 225,106 220,796 237,273 212,101 227,725 199,482 214,018 168,178 180,468 145,410 155,933   
75-84 115,346 152,401 115,880 151,583 117,864 152,361 120,898 154,015 115,625 146,120 108,171 135,339 89,670 111,761 76,803 95,580   
85+ 33,296 71,022 34,527 71,208 35,629 72,291 36,220 71,998 34,839 67,408 33,030 63,439 27,314 51,409 23,916 43,875   
Subtotal 1,326,539 1,398,130 1,316,324 1,389,260 1,317,475 1,395,232 1,337,986 1,414,987 1,256,286 1,328,586 1,163,999 1,230,594 969,252 1,023,864 845,220 889,796   
Total 2,724,669 2,705,584 2,712,707 2,752,973 2,584,872 2,394,593 1,993,116 1,735,016   






Supplementary Table 2. Age-sex specific prevalence of diagnosed AF per 1,000 population in UK primary care, 2000-2016 
Age 
(years) 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 
% Increase 
2000-2016 
Males   
                 
35-44 1.48 1.64 1.68 1.78 1.89 2.08 1.99 1.83 1.69 1.70 1.89 1.90 1.99 2.05 2.10 2.30 2.34 57.8, p < 0.001 
45-54 4.65 4.77 5.13 5.29 5.62 5.86 5.64 5.39 5.42 5.54 5.68 5.90 6.04 6.36 6.75 7.31 7.61 63.7, p < 0.001 
55-64 16.79 17.31 17.26 17.65 18.26 18.82 19.21 19.21 19.59 19.97 20.50 20.74 20.83 21.34 22.05 22.89 24.01 43.0, p < 0.001 
65-74 44.87 47.37 49.66 51.50 53.34 54.90 56.89 56.86 57.15 57.30 57.83 58.41 59.30 60.61 62.53 64.14 66.78 48.8, p < 0.001 
75-84 89.95 95.35 99.47 106.11 111.15 115.06 116.80 119.78 122.66 124.81 128.24 130.75 132.22 135.42 139.04 143.75 147.38 63.8, p < 0.001 
85+ 109.91 123.51 126.70 134.06 146.71 157.30 166.92 173.23 177.27 182.72 189.24 193.83 198.34 200.64 205.90 213.44 220.94 101.0, p < 0.001 
All ages 21.70 23.14 24.00 25.09 26.35 27.49 28.25 28.81 29.52 30.35 31.55 32.68 33.55 34.90 36.39 37.78 38.86 79.1, p < 0.001 
Females   
                 
35-44 0.52 0.49 0.48 0.52 0.59 0.60 0.65 0.61 0.62 0.61 0.64 0.56 0.61 0.71 0.71 0.73 0.73 40.4, p = 0.001 
45-54 1.83 1.88 1.76 1.89 1.93 2.05 1.95 1.87 1.82 1.81 1.88 1.99 2.19 2.39 2.53 2.43 2.55 38.9, p < 0.001 
55-64 7.58 7.70 7.69 8.06 8.14 8.15 8.17 8.18 8.32 8.13 8.33 8.57 8.52 8.51 8.75 8.99 9.28 22.4, p < 0.001 
65-74 27.72 28.53 30.04 30.57 31.78 32.43 32.95 32.74 32.26 32.09 31.89 31.58 31.48 31.61 32.04 32.88 34.25 23.5, p < 0.001 
75-84 65.12 69.24 72.59 77.40 80.61 82.41 83.95 84.45 85.24 85.94 87.27 89.34 90.83 91.51 93.72 96.32 97.56 49.8, p < 0.001 
85+ 95.77 104.36 108.32 116.17 125.98 132.70 137.97 141.76 144.26 146.32 148.47 150.85 151.98 154.25 157.65 157.97 165.33 72.6, p < 0.001 
All ages 18.76 19.84 20.44 21.31 22.33 22.99 23.45 23.70 23.83 24.04 24.45 25.03 25.29 25.76 26.54 26.82 27.33 45.7, p < 0.001 
Both sexes   
                 







Supplementary Table 3. Trends in treatment of patients with AF stratified by 





Population Prescribed Anticoagulants Prescribed Antiplatelets Only Prescribed Neither Treatment 
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) 
2000 Low 1278 5.9 (5.6 to 6.2) 254 19.9 (17.8 to 22.2) 118 9.2 (7.8 to 10.9) 906 70.9 (68.3 to 73.3) 
 
Moderate 1575 7.2 (6.9 to 7.6) 517 32.8 (30.5 to 35.2) 326 20.7 (18.8 to 22.8) 732 46.5 (44.0 to 48.9) 
 




7455 34.3 (33.7 to 34.9) 7042 32.4 (31.8 to 33.0) 7233 33.3 (32.7 to 33.9) 
2001 Low 1647 5.5 (5.2 to 5.7) 296 18.0 (16.2 to 19.9) 177 10.7 (9.3 to 12.3) 1174 71.3 (69.0 to 73.4) 
 
Moderate 2104 7.0 (6.7 to 7.3) 730 34.7 (32.7 to 36.8) 496 23.6 (21.8 to 25.4) 878 41.7 (39.6 to 43.9) 
 




10956 36.5 (35.9 to 37.0) 10159 33.8 (33.3 to 34.4) 8915 29.7 (29.2 to 30.2) 
2002 Low 2077 5.3 (5.1 to 5.5) 390 18.8 (17.2 to 20.5) 226 10.9 (9.6 to 12.3) 1461 70.3 (68.3 to 72.3) 
 
Moderate 2762 7.0 (6.8 to 7.3) 1001 36.2 (34.5 to 38.1) 691 25.0 (23.4 to 26.7) 1070 38.7 (36.9 to 40.6) 
 




14880 37.8 (37.3 to 38.3) 13601 34.5 (34.1 to 35.0) 10897 27.7 (27.2 to 28.1) 
2003 Low 2310 5.0 (4.8 to 5.2) 392 17.0 (15.5 to 18.6) 290 12.6 (11.3 to 14.0) 1628 70.5 (68.6 to 72.3) 
 
Moderate 3191 6.9 (6.7 to 7.2) 1201 37.6 (36.0 to 39.3) 861 27.0 (25.5 to 28.5) 1129 35.4 (33.7 to 37.1) 
 




18215 39.6 (39.2 to 40.1) 16304 35.5 (35.0 to 35.9) 11463 24.9 (24.5 to 25.3) 
2004 Low 2423 4.7 (4.5 to 4.9) 409 16.9 (15.4 to 18.4) 306 12.6 (11.4 to 14.0) 1708 70.5 (68.6 to 72.3) 
 
Moderate 3528 6.8 (6.6 to 7.0) 1376 39.0 (37.4 to 40.6) 952 27.0 (25.5 to 28.5) 1200 34.0 (32.5 to 35.6) 
 




21347 41.3 (40.9 to 41.7) 18591 36.0 (35.6 to 36.4) 11744 22.7 (22.4 to 23.1) 
2005 Low 2698 4.6 (4.4 to 4.7) 467 17.3 (15.9 to 18.8) 335 12.4 (11.2 to 13.7) 1896 70.3 (68.5 to 72.0) 
 
Moderate 4055 6.8 (6.6 to 7.0) 1567 38.6 (37.2 to 40.2) 1125 27.7 (26.4 to 29.1) 1363 33.6 (32.2 to 35.1) 
 




25426 42.9 (42.5 to 43.3) 21131 35.7 (35.3 to 36.0) 12707 21.4 (21.1 to 21.8) 
2006 Low 2641 4.2 (4.0 to 4.4) 479 18.1 (16.7 to 19.7) 485 18.4 (16.9 to 19.9) 1677 63.5 (61.6 to 65.3) 
 
Moderate 4230 6.7 (6.5 to 6.9) 1711 40.4 (39.0 to 41.9) 1325 31.3 (29.9 to 32.7) 1194 28.2 (26.9 to 29.6) 
 




28675 45.5 (45.2 to 45.9) 22951 36.5 (36.1 to 36.8) 11336 18.0 (17.7 to 18.3) 
2007 Low 2403 3.6 (3.5 to 3.8) 423 17.6 (16.1 to 19.2) 590 24.6 (22.9 to 26.3) 1390 57.8 (55.9 to 59.8) 
 
Moderate 4345 6.6 (6.4 to 6.8) 1858 42.8 (41.3 to 44.2) 1489 34.3 (32.9 to 35.7) 998 23.0 (21.7 to 24.2) 
 




31499 47.6 (47.2 to 48.0) 24738 37.4 (37.0 to 37.8) 9914 15.0 (14.7 to 15.3) 
2008 Low 2477 3.5 (3.3 to 3.6) 425 17.2 (15.7 to 18.7) 625 25.2 (23.6 to 27.0) 1427 57.6 (55.7 to 59.5) 
 
Moderate 4630 6.5 (6.3 to 6.6) 1994 43.1 (41.6 to 44.5) 1607 34.7 (33.4 to 36.1) 1029 22.2 (21.1 to 23.4) 
 




35170 49.1 (48.8 to 49.5) 26266 36.7 (36.3 to 37.0) 10169 14.2 (13.9 to 14.5) 
2009 Low 2448 3.3 (3.2 to 3.4) 389 15.9 (14.5 to 17.4) 606 24.8 (23.1 to 26.5) 1453 59.4 (57.4 to 61.3) 
 
Moderate 4727 6.4 (6.2 to 6.6) 1957 41.4 (40.0 to 42.8) 1726 36.5 (35.2 to 37.9) 1044 22.1 (20.9 to 23.3) 
 




36777 49.8 (49.4 to 50.2) 26305 35.6 (35.3 to 36.0) 10783 14.6 (14.3 to 14.9) 
2010 Low 2494 3.3 (3.2 to 3.4) 360 14.4 (13.1 to 15.9) 637 25.5 (23.9 to 27.3) 1497 60.0 (58.1 to 61.9) 
 








38120 50.5 (50.1 to 50.9) 26461 35.1 (34.7 to 35.4) 10909 14.5 (14.2 to 14.7) 
2011 Low 2478 3.2 (3.1 to 3.3) 323 13.0 (11.8 to 14.4) 625 25.2 (23.6 to 27.0) 1530 61.7 (59.8 to 63.6) 
 
Moderate 4891 6.3 (6.1 to 6.4) 1879 38.4 (37.1 to 39.8) 1879 38.4 (37.1 to 39.8) 1133 23.2 (22.0 to 24.4) 
 




40375 51.8 (51.4 to 52.1) 26651 34.2 (33.8 to 34.5) 10950 14.0 (13.8 to 14.3) 
2012 Low 2659 3.3 (3.2 to 3.4) 351 13.2 (12.0 to 14.5) 551 20.7 (19.2 to 22.3) 1757 66.1 (64.3 to 67.9) 
 
Moderate 4912 6.1 (5.9 to 6.3) 1857 37.8 (36.5 to 39.2) 1797 36.6 (35.2 to 37.9) 1258 25.6 (24.4 to 26.9) 
 




44137 54.7 (54.4 to 55.1) 25126 31.1 (30.8 to 31.5) 11411 14.1 (13.9 to 14.4) 
2013 Low 2614 3.3 (3.2 to 3.5) 304 11.6 (10.5 to 12.9) 368 14.1 (12.8 to 15.5) 1942 74.3 (72.6 to 75.9) 
 
Moderate 4726 6.1 (5.9 to 6.2) 1771 37.5 (36.1 to 38.9) 1569 33.2 (31.9 to 34.6) 1386 29.3 (28.0 to 30.6) 
 




45578 58.4 (58.0 to 58.7) 21140 27.1 (26.8 to 27.4) 11354 14.5 (14.3 to 14.8) 
2014 Low 2575 3.4 (3.3 to 3.6) 262 10.2 (9.1 to 11.4) 263 10.2 (9.1 to 11.4) 2050 79.6 (78.0 to 81.1) 
 
Moderate 4575 6.1 (5.9 to 6.3) 1867 40.8 (39.4 to 42.2) 1221 26.7 (25.4 to 28.0) 1487 32.5 (31.2 to 33.9) 
 




46766 62.3 (62.0 to 62.7) 16564 22.1 (21.8 to 22.4) 11690 15.6 (15.3 to 15.8) 
2015 Low 2108 3.3 (3.2 to 3.4) 220 10.4 (9.2 to 11.8) 148 7.0 (6.0 to 8.2) 1740 82.5 (80.9 to 84.1) 
 
Moderate 4030 6.3 (6.1 to 6.5) 1806 44.8 (43.3 to 46.4) 777 19.3 (18.1 to 20.5) 1447 35.9 (34.4 to 37.4) 
 




43719 68.2 (67.9 to 68.6) 10263 16.0 (15.7 to 16.3) 10098 15.8 (15.5 to 16.0) 
2016 Low 1917 3.4 (3.2 to 3.5) 185 9.7 (8.4 to 11.1) 93 4.9 (4.0 to 5.9) 1639 85.5 (83.8 to 87.0) 
 
Moderate 3603 6.3 (6.1 to 6.5) 1696 47.1 (45.4 to 48.7) 537 14.9 (13.8 to 16.1) 1370 38.0 (36.5 to 39.6) 
 
High 51641 90.3 (90.1 to 90.6) 38977 75.5 (75.1 to 75.8) 6370 12.3 (12.1 to 12.6) 6294 12.2 (11.9 to 12.5) 





Supplementary Table 4. Trends in treatment of patients with AF stratified by CHADS2 
score, 2000-2016 
Year CHADS2 Stroke Risk 
Population Prescribed Anticoagulants Prescribed Antiplatelets Only Prescribed Neither Treatment 
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) 
2000 Low 2548 11.7 (11.3 to 12.2) 646 25.4 (23.7 to 27.1) 396 15.5 (14.2 to 17.0) 1506 59.1 (57.2 to 61.0) 
 
Moderate 6161 28.4 (27.8 to 29.0) 1985 32.2 (31.1 to 33.4) 1819 29.5 (28.4 to 30.7) 2357 38.3 (37.1 to 39.5) 
 




7455 34.3 (33.7 to 34.9) 7042 32.4 (31.8 to 33.0) 7233 33.3 (32.7 to 33.9) 
2001 Low 3261 10.9 (10.5 to 11.2) 823 25.2 (23.8 to 26.8) 550 16.9 (15.6 to 18.2) 1888 57.9 (56.2 to 59.6) 
 
Moderate 8282 27.6 (27.1 to 28.1) 2823 34.1 (33.1 to 35.1) 2634 31.8 (30.8 to 32.8) 2825 34.1 (33.1 to 35.1) 
 




10956 36.5 (35.9 to 37.0) 10159 33.8 (33.3 to 34.4) 8915 29.7 (29.2 to 30.2) 
2002 Low 4037 10.3 (10.0 to 10.6) 1040 25.8 (24.4 to 27.1) 694 17.2 (16.1 to 18.4) 2303 57.0 (55.5 to 58.6) 
 
Moderate 10784 27.4 (26.9 to 27.8) 3785 35.1 (34.2 to 36.0) 3568 33.1 (32.2 to 34.0) 3431 31.8 (30.9 to 32.7) 
 




14880 37.8 (37.3 to 38.3) 13601 34.5 (34.1 to 35.0) 10897 27.7 (27.2 to 28.1) 
2003 Low 4482 9.7 (9.5 to 10.0) 1154 25.7 (24.5 to 27.0) 850 19.0 (17.8 to 20.1) 2478 55.3 (53.8 to 56.7) 
 
Moderate 12361 26.9 (26.5 to 27.3) 4566 36.9 (36.1 to 37.8) 4147 33.5 (32.7 to 34.4) 3648 29.5 (28.7 to 30.3) 
 




18215 39.6 (39.2 to 40.1) 16304 35.5 (35.0 to 35.9) 11463 24.9 (24.5 to 25.3) 
2004 Low 4618 8.9 (8.7 to 9.2) 1192 25.8 (24.6 to 27.1) 894 19.4 (18.2 to 20.5) 2532 54.8 (53.4 to 56.3) 
 
Moderate 13758 26.6 (26.2 to 27.0) 5355 38.9 (38.1 to 39.7) 4640 33.7 (32.9 to 34.5) 3763 27.4 (26.6 to 28.1) 
 




21347 41.3 (40.9 to 41.7) 18591 36.0 (35.6 to 36.4) 11744 22.7 (22.4 to 23.1) 
2005 Low 5020 8.5 (8.2 to 8.7) 1308 26.1 (24.9 to 27.3) 942 18.8 (17.7 to 19.9) 2770 55.2 (53.8 to 56.6) 
 
Moderate 15727 26.5 (26.2 to 26.9) 6320 40.2 (39.4 to 41.0) 5313 33.8 (33.0 to 34.5) 4094 26.0 (25.4 to 26.7) 
 




25426 42.9 (42.5 to 43.3) 21131 35.7 (35.3 to 36.0) 12707 21.4 (21.1 to 21.8) 
2006 Low 4918 7.8 (7.6 to 8.0) 1357 27.6 (26.4 to 28.9) 1132 23.0 (21.9 to 24.2) 2429 49.4 (48.0 to 50.8) 
 
Moderate 16554 26.3 (25.9 to 26.6) 7119 43.0 (42.3 to 43.8) 5879 35.5 (34.8 to 36.2) 3556 21.5 (20.9 to 22.1) 
 




28675 45.5 (45.2 to 45.9) 22951 36.5 (36.1 to 36.8) 11336 18.0 (17.7 to 18.3) 
2007 Low 4597 6.9 (6.8 to 7.1) 1297 28.2 (26.9 to 29.5) 1273 27.7 (26.4 to 29.0) 2027 44.1 (42.7 to 45.5) 
 
Moderate 17035 25.8 (25.4 to 26.1) 7733 45.4 (44.6 to 46.1) 6339 37.2 (36.5 to 37.9) 2963 17.4 (16.8 to 18.0) 
 




31499 47.6 (47.2 to 48.0) 24738 37.4 (37.0 to 37.8) 9914 15.0 (14.7 to 15.3) 
2008 Low 4760 6.6 (6.5 to 6.8) 1382 29.0 (27.8 to 30.3) 1313 27.6 (26.3 to 28.9) 2065 43.4 (42.0 to 44.8) 
 
Moderate 18248 25.5 (25.2 to 25.8) 8363 45.8 (45.1 to 46.6) 6835 37.5 (36.8 to 38.2) 3050 16.7 (16.2 to 17.3) 
 




35170 49.1 (48.8 to 49.5) 26266 36.7 (36.3 to 37.0) 10169 14.2 (13.9 to 14.5) 
2009 Low 4674 6.3 (6.2 to 6.5) 1254 26.8 (25.6 to 28.1) 1277 27.3 (26.1 to 28.6) 2143 45.8 (44.4 to 47.3) 
 
Moderate 18641 25.2 (24.9 to 25.6) 8409 45.1 (44.4 to 45.8) 7013 37.6 (36.9 to 38.3) 3219 17.3 (16.7 to 17.8) 
 




36777 49.8 (49.4 to 50.2) 26305 35.6 (35.3 to 36.0) 10783 14.6 (14.3 to 14.9) 
2010 Low 4603 6.1 (5.9 to 6.3) 1130 24.5 (23.3 to 25.8) 1305 28.4 (27.1 to 29.7) 2168 47.1 (45.7 to 48.5) 
 
Moderate 18855 25.0 (24.7 to 25.3) 8369 44.4 (43.7 to 45.1) 7172 38.0 (37.3 to 38.7) 3314 17.6 (17.0 to 18.1) 
 






38120 50.5 (50.1 to 50.9) 26461 35.1 (34.7 to 35.4) 10909 14.5 (14.2 to 14.7) 
2011 Low 4640 6.0 (5.8 to 6.1) 1055 22.7 (21.6 to 24.0) 1325 28.6 (27.3 to 29.9) 2260 48.7 (47.3 to 50.1) 
 
Moderate 19373 24.8 (24.5 to 25.1) 8605 44.4 (43.7 to 45.1) 7503 38.7 (38.0 to 39.4) 3265 16.9 (16.3 to 17.4) 
 




40375 51.8 (51.4 to 52.1) 26651 34.2 (33.8 to 34.5) 10950 14.0 (13.8 to 14.3) 
2012 Low 4902 6.1 (5.9 to 6.2) 1113 22.7 (21.6 to 23.9) 1240 25.3 (24.1 to 26.5) 2549 52.0 (50.6 to 53.4) 
 
Moderate 19941 24.7 (24.4 to 25.0) 9177 46.0 (45.3 to 46.7) 7266 36.4 (35.8 to 37.1) 3498 17.5 (17.0 to 18.1) 
 




44137 54.7 (54.4 to 55.1) 25126 31.1 (30.8 to 31.5) 11411 14.1 (13.9 to 14.4) 
2013 Low 4761 6.1 (5.9 to 6.3) 1014 21.3 (20.2 to 22.5) 954 20.0 (18.9 to 21.2) 2793 58.7 (57.3 to 60.1) 
 
Moderate 19075 24.4 (24.1 to 24.7) 9373 49.1 (48.4 to 49.8) 6250 32.8 (32.1 to 33.4) 3452 18.1 (17.6 to 18.6) 
 




45578 58.4 (58.0 to 58.7) 21140 27.1 (26.8 to 27.4) 11354 14.5 (14.3 to 14.8) 
2014 Low 4657 6.2 (6.0 to 6.4) 1013 21.8 (20.6 to 23.0) 743 16.0 (14.9 to 17.0) 2901 62.3 (60.9 to 63.7) 
 
Moderate 18156 24.2 (23.9 to 24.5) 9825 54.1 (53.4 to 54.8) 4785 26.4 (25.7 to 27.0) 3546 19.5 (19.0 to 20.1) 
 




46766 62.3 (62.0 to 62.7) 16564 22.1 (21.8 to 22.4) 11690 15.6 (15.3 to 15.8) 
2015 Low 3797 5.9 (5.7 to 6.1) 908 23.9 (22.6 to 25.3) 405 10.7 (9.7 to 11.7) 2484 65.4 (63.9 to 66.9) 
 
Moderate 15431 24.1 (23.8 to 24.4) 9291 60.2 (59.4 to 61.0) 2953 19.1 (18.5 to 19.8) 3187 20.7 (20.0 to 21.3) 
 




43719 68.2 (67.9 to 68.6) 10263 16.0 (15.7 to 16.3) 10098 15.8 (15.5 to 16.0) 
2016 Low 3427 6.0 (5.8 to 6.2) 865 25.2 (23.8 to 26.7) 261 7.6 (6.8 to 8.6) 2301 67.1 (65.6 to 68.7) 
 
Moderate 13879 24.3 (23.9 to 24.6) 8799 63.4 (62.6 to 64.2) 2014 14.5 (13.9 to 15.1) 3066 22.1 (21.4 to 22.8) 
 
High 39855 69.7 (69.3 to 70.1) 31194 78.3 (77.9 to 78.7) 4725 11.9 (11.5 to 12.2) 3936 9.9 (9.6 to 10.2) 
 





Supplementary Table 5. Trends in treatment of patients with AF stratified by 
CHA2DS2-VASc score and presence/absence of contraindications, 2000-2016 
Year CHA2DS2-VASc Stroke Risk/Contraindications 
Population Prescribed Anticoagulants Prescribed Antiplatelets Only Prescribed Neither Treatment 
n % (95% CI) n % (95% CI) n % (95% CI) n % (95% CI) 
2000 Low or contraindicated 2399 11.0 (10.6 to 11.5) 674 28.1 (26.3 to 29.9) 472 19.7 (18.1 to 21.3) 1253 52.2 (50.2 to 54.2) 
 
Moderate 1510 6.9 (6.6 to 7.3) 495 32.8 (30.5 to 35.2) 310 20.5 (18.6 to 22.6) 705 46.7 (44.2 to 49.2) 
 




7455 34.3 (33.7 to 34.9) 7042 32.4 (31.8 to 33.0) 7233 33.3 (32.7 to 33.9) 
2001 Low or contraindicated 3375 11.2 (10.9 to 11.6) 944 28.0 (26.5 to 29.5) 746 22.1 (20.7 to 23.5) 1685 49.9 (48.2 to 51.6) 
 
Moderate 2011 6.7 (6.4 to 7.0) 704 35.0 (33.0 to 37.1) 473 23.5 (21.7 to 25.4) 834 41.5 (39.3 to 43.6) 
 




10956 36.5 (35.9 to 37.0) 10159 33.8 (33.3 to 34.4) 8915 29.7 (29.2 to 30.2) 
2002 Low or contraindicated 4500 11.4 (11.1 to 11.7) 1333 29.6 (28.3 to 31.0) 1062 23.6 (22.4 to 24.9) 2105 46.8 (45.3 to 48.2) 
 
Moderate 2614 6.6 (6.4 to 6.9) 947 36.2 (34.4 to 38.1) 650 24.9 (23.2 to 26.6) 1017 38.9 (37.1 to 40.8) 
 




14880 37.8 (37.3 to 38.3) 13601 34.5 (34.1 to 35.0) 10897 27.7 (27.2 to 28.1) 
2003 Low or contraindicated 5209 11.3 (11.0 to 11.6) 1575 30.2 (29.0 to 31.5) 1333 25.6 (24.4 to 26.8) 2301 44.2 (42.8 to 45.5) 
 
Moderate 3035 6.6 (6.4 to 6.8) 1136 37.4 (35.7 to 39.2) 811 26.7 (25.2 to 28.3) 1088 35.8 (34.2 to 37.6) 
 




18215 39.6 (39.2 to 40.1) 16304 35.5 (35.0 to 35.9) 11463 24.9 (24.5 to 25.3) 
2004 Low or contraindicated 5674 11.0 (10.7 to 11.3) 1784 31.4 (30.2 to 32.7) 1443 25.4 (24.3 to 26.6) 2447 43.1 (41.8 to 44.4) 
 
Moderate 3372 6.5 (6.3 to 6.7) 1308 38.8 (37.2 to 40.4) 911 27.0 (25.5 to 28.5) 1153 34.2 (32.6 to 35.8) 
 




21347 41.3 (40.9 to 41.7) 18591 36.0 (35.6 to 36.4) 11744 22.7 (22.4 to 23.1) 
2005 Low or contraindicated 6305 10.6 (10.4 to 10.9) 2024 32.1 (31.0 to 33.3) 1575 25.0 (23.9 to 26.1) 2706 42.9 (41.7 to 44.1) 
 
Moderate 3881 6.5 (6.4 to 6.8) 1499 38.6 (37.1 to 40.2) 1072 27.6 (26.2 to 29.1) 1310 33.8 (32.3 to 35.3) 
 




25426 42.9 (42.5 to 43.3) 21131 35.7 (35.3 to 36.0) 12707 21.4 (21.1 to 21.8) 
2006 Low or contraindicated 6306 10.0 (9.8 to 10.3) 2161 34.3 (33.1 to 35.4) 1738 27.6 (26.5 to 28.7) 2407 38.2 (37.0 to 39.4) 
 
Moderate 4062 6.5 (6.3 to 6.6) 1631 40.2 (38.7 to 41.7) 1275 31.4 (30.0 to 32.8) 1156 28.5 (27.1 to 29.9) 
 




28675 45.5 (45.2 to 45.9) 22951 36.5 (36.1 to 36.8) 11336 18.0 (17.7 to 18.3) 
2007 Low or contraindicated 6203 9.4 (9.2 to 9.6) 2225 35.9 (34.7 to 37.1) 1932 31.1 (30.0 to 32.3) 2046 33.0 (31.8 to 34.2) 
 
Moderate 4167 6.3 (6.1 to 6.5) 1774 42.6 (41.1 to 44.1) 1428 34.3 (32.8 to 35.7) 965 23.2 (21.9 to 24.5) 
 




31499 47.6 (47.2 to 48.0) 24738 37.4 (37.0 to 37.8) 9914 15.0 (14.7 to 15.3) 
2008 Low or contraindicated 6631 9.3 (9.1 to 9.5) 2478 37.4 (36.2 to 38.5) 1983 29.9 (28.8 to 31.0) 2170 32.7 (31.6 to 33.9) 
 
Moderate 4421 6.2 (6.0 to 6.4) 1897 42.9 (41.5 to 44.4) 1548 35.0 (33.6 to 36.4) 976 22.1 (20.9 to 23.3) 
 




35170 49.1 (48.8 to 49.5) 26266 36.7 (36.3 to 37.0) 10169 14.2 (13.9 to 14.5) 
2009 Low or contraindicated 6874 9.3 (9.1 to 9.5) 2637 38.4 (37.2 to 39.5) 2030 29.5 (28.5 to 30.6) 2207 32.1 (31.0 to 33.2) 
 
Moderate 4537 6.1 (6.0 to 6.3) 1870 41.2 (39.8 to 42.7) 1668 36.8 (35.4 to 38.2) 999 22.0 (20.8 to 23.2) 
 




36777 49.8 (49.4 to 50.2) 26305 35.6 (35.3 to 36.0) 10783 14.6 (14.3 to 14.9) 
2010 Low or contraindicated 6930 9.2 (9.0 to 9.4) 2607 37.6 (36.5 to 38.8) 2057 29.7 (28.6 to 30.8) 2266 32.7 (31.6 to 33.8) 
 
Moderate 4548 6.0 (5.9 to 6.2) 1802 39.6 (38.2 to 41.1) 1680 36.9 (35.5 to 38.4) 1066 23.4 (22.2 to 24.7) 
 






38120 50.5 (50.1 to 50.9) 26461 35.1 (34.7 to 35.4) 10909 14.5 (14.2 to 14.7) 
2011 Low or contraindicated 7002 9.0 (8.8 to 9.2) 2685 38.3 (37.2 to 39.5) 2048 29.2 (28.2 to 30.3) 2269 32.4 (31.3 to 33.5) 
 
Moderate 4701 6.0 (5.9 to 6.2) 1791 38.1 (36.7 to 39.5) 1817 38.7 (37.3 to 40.1) 1093 23.3 (22.1 to 24.5) 
 




40375 51.8 (51.4 to 52.1) 26651 34.2 (33.8 to 34.5) 10950 14.0 (13.8 to 14.3) 
2012 Low or contraindicated 7390 9.2 (9.0 to 9.4) 2978 40.3 (39.2 to 41.4) 1912 25.9 (24.9 to 26.9) 2500 33.8 (32.8 to 34.9) 
 
Moderate 4726 5.9 (5.7 to 6.0) 1780 37.7 (36.3 to 39.1) 1731 36.6 (35.3 to 38.0) 1215 25.7 (24.5 to 27.0) 
 




44137 54.7 (54.4 to 55.1) 25126 31.1 (30.8 to 31.5) 11411 14.1 (13.9 to 14.4) 
2013 Low or contraindicated 7209 9.2 (9.0 to 9.4) 2992 41.5 (40.4 to 42.6) 1534 21.3 (20.3 to 22.2) 2683 37.2 (36.1 to 38.3) 
 
Moderate 4561 5.8 (5.7 to 6.0) 1696 37.2 (35.8 to 38.6) 1520 33.3 (32.0 to 34.7) 1345 29.5 (28.2 to 30.8) 
 




45578 58.4 (58.0 to 58.7) 21140 27.1 (26.8 to 27.4) 11354 14.5 (14.3 to 14.8) 
2014 Low or contraindicated 6842 9.1 (8.9 to 9.3) 2948 43.1 (41.9 to 44.3) 1130 16.5 (15.7 to 17.4) 2764 40.4 (39.2 to 41.6) 
 
Moderate 4411 5.9 (5.7 to 6.1) 1799 40.8 (39.3 to 42.2) 1178 26.7 (25.4 to 28.0) 1434 32.5 (31.1 to 33.9) 
 




46766 62.3 (62.0 to 62.7) 16564 22.1 (21.8 to 22.4) 11690 15.6 (15.3 to 15.8) 
2015 Low or contraindicated 5668 8.8 (8.6 to 9.1) 2653 46.8 (45.5 to 48.1) 663 11.7 (10.9 to 12.6) 2352 41.5 (40.2 to 42.8) 
 
Moderate 3876 6.0 (5.9 to 6.2) 1722 44.4 (42.9 to 46.0) 750 19.3 (18.1 to 20.6) 1404 36.2 (34.7 to 37.7) 
 




43719 68.2 (67.9 to 68.6) 10263 16.0 (15.7 to 16.3) 10098 15.8 (15.5 to 16.0) 
2016 Low or contraindicated 4929 8.6 (8.4 to 8.9) 2340 47.5 (46.1 to 48.9) 441 8.9 (8.2 to 9.8) 2148 43.6 (42.2 to 45.0) 
 
Moderate 3481 6.1 (5.9 to 6.3) 1634 46.9 (45.3 to 48.6) 519 14.9 (13.8 to 16.1) 1328 38.1 (36.5 to 39.8) 
 
High 48751 85.3 (85.0 to 85.6) 36884 75.7 (75.3 to 76.0) 6040 12.4 (12.1 to 12.7) 5827 12.0 (11.7 to 12.2) 
 






Supplementary Figure 1. Proportion of patients with AF prescribed anticoagulants 







































































Eligible CHADS2 ≥ 2
All AF
Eligible CHADS2 = 1




Supplementary Figure 2. Proportion of patients with AF prescribed anticoagulants 








































































Eligible CHADS-VASc ≥ 2 and no contraindications
All AF
Eligible CHADS-VASc = 1 and male and no contraindications




  2016 




1 4.7% 6.2% 2.5% 3.3% 3.6% 
2 4.3% 5.1% 4.0% 4.3% 2.2% 
3 4.7% 3.6% 3.3% 3.6% 4.7% 
4 3.6% 2.2% 6.2% 4.0% 4.0% 
5 2.9% 2.9% 4.0% 4.7% 5.4% 
 
Supplementary Figure 3. Percentage of practices (n = 276) in each anticoagulant 
prescribing quintile in 2006 and 2016 
